Daré Bioscience announced its investigational device, DARE-IDDS, a programmable, wireless implant designed to deliver over 100 doses over months or years, aiming to reduce the burden of repeated injections in chronic therapies. Initially targeted for contraception, this device allows remote monitoring and dose adjustment, potentially improving treatment adherence and patient convenience. The technology is still in preclinical development and has not yet been approved for human use. Daré Bioscience plans to explore broader therapeutic applications and partnerships for this platform.
Daré Bioscience's investigational programmable device DARE-IDDS aims to deliver over 100 doses wirelessly, offering a new approach to chronic therapy management. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 26, 2026 19:02 WIB: out of 150 priced US health stocks, 78 rose and 48 fell. Notable movers include ClearPoint Neuro Inc (CLPT) at USD 9.38 with a +2.63% change and a typical hold time of 11 days, Viatris Inc (VTRS) at USD 18.44 with a +2.44% change and a 57-day hold time, and GeneDx Holdings Corp (WGS) at USD 57.50 with a +2.40% change and a 20-day hold time.
Smithfield Foods has created a $250,000 Future Leaders Scholarship program at Christopher Newport University to support eight incoming business students with $7,500 annual scholarships renewable for up to four years. The program aims to help local st...
E-Power Inc.'s joint venture, Sunrise Guizhou, received RMB 110 million of a planned RMB 200 million capital increase, raising its registered capital and valuing the company at RMB 2 billion post-money. The funds will support business expansion, R&D,...
AS Tallinna Sadam has signed a €50 million unsecured loan agreement with Swedbank, with a 5-year term and interest based on 3-month Euribor plus a margin. The loan will be fully drawn on October 26, 2026, and matures on October 26, 2031. This financi...
AS Tallinna Sadam signed a €50 million unsecured loan agreement with AS Swedbank, maturing in five years with an interest rate based on 3-month Euribor plus margin. The loan, drawn on October 26, 2026, will be used to redeem bonds worth €50.4 million...
Vita Coco, a leading coconut water brand, has partnered with Homesick to create a limited-edition candle collection inspired by Vita Coco Treats flavors: Strawberries & Creme and Frosted Lemonade. The candles capture the essence of these flavors thro...
